Claire Feeney

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Eric L. Simpson, Rodney Sinclair, Seth Forman et al. · The Lancet · 2020 · 452 citations · Full text

Allergy, Atopic Dermatitis, Medicine +9

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis

Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen et al. · JAMA Dermatology · 2020 · 363 citations · Full text

Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration

Gregory Scott, Henrik Zetterberg, Amy Jolly et al. · Brain · 2017 · 205 citations · Full text

Neurodegenerative Diseases, Traumatic Brain Injury, Brain Trauma +15

Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis

Lawrence F. Eichenfield, Carsten Flohr, Robert Sidbury et al. · JAMA Dermatology · 2021 · 148 citations · Full text

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial

Andrew Blauvelt, Jonathan I. Silverberg, Charles Lynde et al. · Journal of the American Academy of Dermatology · 2021 · 140 citations · Full text